NASDAQ has granted an extension only through February 16, 2026, for Urgent.ly ( ULY +0.78%) to meet continued listing ...

Non-GAAP Gross Profit Margin -- 19.9%, up slightly sequentially but down 120 basis points year over year due to lower cost ...

Aftermarket antenna and enterprise custom products continue to be negatively affected by channel inventory overhang, largely ...

Heartflow expects total revenue for the full year 2025 to be in the range of $173.0 million to $173.5 million, representing year-over-year growth of approximately 37.5% to 38.0%.

Company Reports Record Quarterly Revenue of $4.8 Million; Net Loss and Loss per Diluted Share of $5.2 Million and $3.11; ...

On October 15, 2025, the Company paid a cash dividend of $0.30 per common share for the third quarter of 2025. SUNS distributed $4.0 million in dividends, or $0.30 per common share, compared to ...

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...

Stock Repurchase: On October 3, 2025, GameSquare announced its initial stock repurchase under its previously announced $5 ...

Figma is proving to be a fast-growing AI-powered collaborative design platform, ready for the next phase of expansion.

SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025.

Operator: Good day, and welcome to eGain Corporation Fiscal 2026 First Quarter Financial Results Call. All participants will ...

Highlights for the Quarter ended September 30, 2025: Management and advisory fee revenue of $17.8 million for the quarter ended September 30, 2025, a 36% increase from the third quarter of 2024 ...